Analysts Anticipate Sabra Health Care REIT Inc (NASDAQ:SBRA) Will Post Quarterly Sales of $153.42 Million

Brokerages expect that Sabra Health Care REIT Inc (NASDAQ:SBRA) will report sales of $153.42 million for the current quarter, according to Zacks. Three analysts have provided estimates for Sabra Health Care REIT’s earnings, with the lowest sales estimate coming in at $127.65 million and the highest estimate coming in at $196.68 million. Sabra Health Care REIT posted sales of $166.31 million in the same quarter last year, which suggests a negative year-over-year growth rate of 7.8%. The business is expected to report its next earnings report on Wednesday, August 14th.

According to Zacks, analysts expect that Sabra Health Care REIT will report full-year sales of $558.12 million for the current year, with estimates ranging from $521.67 million to $598.22 million. For the next financial year, analysts forecast that the business will post sales of $558.85 million, with estimates ranging from $521.54 million to $589.85 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that that provide coverage for Sabra Health Care REIT.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Wednesday, May 8th. The real estate investment trust reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.94). Sabra Health Care REIT had a net margin of 23.38% and a return on equity of 4.25%. The firm had revenue of $136.77 million for the quarter, compared to the consensus estimate of $144.87 million.

A number of research firms recently weighed in on SBRA. TheStreet downgraded shares of Sabra Health Care REIT from a “b-” rating to a “c+” rating in a research note on Monday, July 1st. BidaskClub downgraded shares of Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Thursday, July 11th. Finally, Zacks Investment Research downgraded shares of Gold Resource from a “hold” rating to a “sell” rating in a research note on Friday, June 21st. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $20.50.

Several institutional investors have recently added to or reduced their stakes in SBRA. Centersquare Investment Management LLC boosted its holdings in shares of Sabra Health Care REIT by 319,577.4% in the first quarter. Centersquare Investment Management LLC now owns 3,219,151 shares of the real estate investment trust’s stock valued at $62,676,000 after buying an additional 3,218,144 shares during the period. Principal Financial Group Inc. lifted its position in shares of Sabra Health Care REIT by 342.1% in the first quarter. Principal Financial Group Inc. now owns 3,490,597 shares of the real estate investment trust’s stock worth $67,962,000 after purchasing an additional 2,701,133 shares in the last quarter. Norges Bank bought a new stake in shares of Sabra Health Care REIT in the fourth quarter worth $35,964,000. D. E. Shaw & Co. Inc. raised its position in Sabra Health Care REIT by 5,219.7% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 913,811 shares of the real estate investment trust’s stock worth $15,060,000 after acquiring an additional 896,633 shares in the last quarter. Finally, Nordea Investment Management AB bought a new stake in Sabra Health Care REIT during the fourth quarter worth $8,795,000. Institutional investors own 89.38% of the company’s stock.

Shares of NASDAQ SBRA traded down $0.73 during trading on Tuesday, reaching $19.98. The company had a trading volume of 1,068,972 shares, compared to its average volume of 1,168,828. Sabra Health Care REIT has a 52 week low of $15.70 and a 52 week high of $23.83. The stock has a market cap of $3.59 billion, a PE ratio of 8.72, a PEG ratio of 11.14 and a beta of 0.89. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 1.06. The business’s 50 day moving average is $19.80.

About Sabra Health Care REIT

As of December 31, 2018, Sabra's investment portfolio included 470 real estate properties held for investment (consisting of (i) 335 Skilled Nursing/Transitional Care facilities, (ii) 90 Senior Housing communities (“Senior Housing – Leased”), (iii) 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing – Managed”) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan and (iv) 18 other loans), nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Read More: Diluted Earnings Per Share

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.